Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Monte Rosa Therapeutics (GLUE) Tax Rate (2023 - 2025)

Monte Rosa Therapeutics' Tax Rate history spans 3 years, with the latest figure at 0.13% for Q4 2025.

  • For Q4 2025, Tax Rate fell 346.0% year-over-year to 0.13%; the TTM value through Dec 2025 reached 2.76%, up 1525.0%, while the annual FY2025 figure was 2.76%, 1517.0% up from the prior year.
  • Tax Rate reached 0.13% in Q4 2025 per GLUE's latest filing, down from 10.5% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 10.5% in Q3 2025 to a low of 10.81% in Q2 2025.
  • Average Tax Rate over 3 years is 0.2%, with a median of 0.3% recorded in 2024.
  • The largest YoY upside for Tax Rate was 1080bps in 2025 against a maximum downside of -997bps in 2025.
  • A 3-year view of Tax Rate shows it stood at 0.07% in 2023, then skyrocketed by 4934bps to 3.33% in 2024, then crashed by -104bps to 0.13% in 2025.
  • Per Business Quant, the three most recent readings for GLUE's Tax Rate are 0.13% (Q4 2025), 10.5% (Q3 2025), and 10.81% (Q2 2025).